Merck & Co (MRK): pharmacist Merck & Co reported a quarterly profit that exceeded analysts' forecasts, but sales do not have lasted up to expectations due to increased competition in the production of generics. Thus, in the first quarter net profit rose to $ 1.04 billion, or 34 cents per share a year earlier to $ 1.74 billion, or 56 cents a share.Excluding special items profit was 99 cents per paper, analysts on average expected 98 cents on the paper. Revenue in the period under review totaled $ 11.73 billion with an average forecast of analysts at $ 11.82 billion. MRK in premarket rose to $ 38.80 (+0.86%).

Procter & Gamble (PG): consumer goods manufacturer Procter & Gamble recorded lower profits in the third quarter of fiscal year due to additional costs on the background of business restructuring, as well as rising prices for raw materials. Thus, the company's profit was $ 2.41 billion, or 82 cents per share, compared with $ 2.87 billion, or 96 cents a year earlier paper. In fact, core profit reached 94 cents a share, while analysts expected 93 cents. Sales for the period under review increased by 2% to $ 20.19 billion. PG in premarket fell to $ 65.25 (-2.42%).